News & Articles

TCR and CAR libraries enable comprehensive screening of combinations of custom gene parts including domains from TCRs and CARs

Posters presented at PEGS Boston 2022 highlight how Twist Bioscience’s next-generation libraries enable antibody discovery for a range of therapies

Population genetics sequencing panel incorporates global genetic variations for superior study of disease and target discovery

The kit offers a high uniformity, high-yield amplification, streamlined NGS workflow for targeted applications

Twist Biopharma will leverage its biologics and proprietary discovery capabilities to find novel GPCR target-specific antibodies for Kyowa Kirin

The assay has the ability to sequence and surveil evolution of virus mutations over time and geography

The combined offering is designed to provide researchers with high quality tools to diagnose cancer and selected genetic disease

RNA controls can help avoid false negative results

The assay is developed for use in detection, characterisation, and monitoring of the SARS-CoV-2 virus

Partnership combines Twist’s leadership in DNA synthesis and synthetic biology with Neogene’s expertise in personalized engineered T cell therapies

The partnership aims to bring access to Twist's proprietary phage display libraries for the discovery of antibodies in Takeda's biologics pipeline

The panel will be bundled with an analysis platform from One Codex designed to enable an easy-to-use, complete end-to-end workflow that begins from the Twist target enrichment panel and continues through publication-ready visualizations